Innospec Inc. (NASDAQ:IOSP) Shares Purchased by Cerity Partners LLC

Cerity Partners LLC lifted its position in Innospec Inc. (NASDAQ:IOSP - Free Report) by 324.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 13,664 shares of the specialty chemicals company's stock after acquiring an additional 10,445 shares during the quarter. Cerity Partners LLC owned 0.05% of Innospec worth $1,545,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in IOSP. Assenagon Asset Management S.A. lifted its holdings in Innospec by 98.4% during the 2nd quarter. Assenagon Asset Management S.A. now owns 120,082 shares of the specialty chemicals company's stock valued at $14,841,000 after buying an additional 59,554 shares in the last quarter. US Bancorp DE increased its position in Innospec by 323.6% during the 3rd quarter. US Bancorp DE now owns 5,490 shares of the specialty chemicals company's stock valued at $621,000 after purchasing an additional 4,194 shares during the period. SG Americas Securities LLC increased its position in Innospec by 660.1% during the 2nd quarter. SG Americas Securities LLC now owns 9,767 shares of the specialty chemicals company's stock valued at $1,207,000 after purchasing an additional 8,482 shares during the period. Quest Partners LLC increased its position in Innospec by 2,699.6% during the 2nd quarter. Quest Partners LLC now owns 13,802 shares of the specialty chemicals company's stock valued at $1,706,000 after purchasing an additional 13,309 shares during the period. Finally, TD Asset Management Inc increased its position in Innospec by 58.9% during the 2nd quarter. TD Asset Management Inc now owns 17,000 shares of the specialty chemicals company's stock valued at $2,101,000 after purchasing an additional 6,300 shares during the period. Institutional investors own 96.64% of the company's stock.

Innospec Stock Down 0.4 %

Shares of Innospec stock traded down $0.48 on Wednesday, reaching $118.97. The stock had a trading volume of 92,971 shares, compared to its average volume of 109,223. The company has a 50 day moving average price of $114.81 and a 200 day moving average price of $118.08. Innospec Inc. has a 1 year low of $103.97 and a 1 year high of $133.71. The stock has a market capitalization of $2.97 billion, a P/E ratio of 20.85 and a beta of 1.09.

Innospec (NASDAQ:IOSP - Get Free Report) last issued its quarterly earnings data on Tuesday, November 5th. The specialty chemicals company reported $1.35 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $1.35. The firm had revenue of $443.40 million for the quarter, compared to the consensus estimate of $442.13 million. Innospec had a net margin of 7.68% and a return on equity of 13.33%. The company's quarterly revenue was down 4.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.59 EPS. On average, analysts forecast that Innospec Inc. will post 5.88 earnings per share for the current fiscal year.

Innospec Increases Dividend

The business also recently announced a Semi-Annual dividend, which was paid on Tuesday, November 26th. Shareholders of record on Monday, November 18th were given a dividend of $0.79 per share. This represents a yield of 1.3%. The ex-dividend date of this dividend was Monday, November 18th. This is an increase from Innospec's previous Semi-Annual dividend of $0.72. Innospec's payout ratio is currently 27.57%.

Insiders Place Their Bets

In other Innospec news, Director Milton C. Blackmore sold 1,035 shares of Innospec stock in a transaction that occurred on Wednesday, November 13th. The shares were sold at an average price of $122.92, for a total transaction of $127,222.20. Following the completion of the sale, the director now directly owns 9,028 shares in the company, valued at approximately $1,109,721.76. The trade was a 10.29 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 1.35% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded shares of Innospec from a "strong-buy" rating to a "buy" rating in a research report on Thursday, August 8th.

Innospec Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.